Skip links
Companies
› Canada › Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc.

Public Limited Company Active

Registration No.
N/A
Incorporation Date
Not disclosed
Company Type
Public Limited Company
Address
Edmonton, Canada
Website
www.auriniapharma.com/
Source: Alberta Corporate Registry

Aurinia Pharmaceuticals Inc. is a Public Limited Company registered in Canada, and its current status with Alberta Corporate Registry is active. Its registered address on file is Edmonton, Canada. 5 shareholders are on record for Aurinia Pharmaceuticals Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Alberta Corporate Registry and was last updated on 28 September 2026.

Data Provenance
This record is sourced directly from official government registries, including Alberta Corporate Registry.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

5

Shareholders of Aurinia Pharmaceuticals Inc.

Five shareholders are currently on record for Aurinia Pharmaceuticals Inc., reflecting the securities register maintained under sections 20 and 50 of the Canada Business Corporations Act rather than a public filing. The largest of these is Tang Capital Management, LLC, holding 27.8% — the largest recorded stake — followed by Arrowstreet Capital, Limited Partnership at 8.3%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Data availability

The register reports 16 shareholders in total, though only the top 5 by holding are shown in this view.

Data-provider feed — rows as supplied to Zavia for Alberta Corporate Registry, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Shareholder Type Holding Source Document
Tang Capital Management, LLC 27.8% Alberta Corporate Registry
Arrowstreet Capital, Limited Partnership 8.3% Alberta Corporate Registry
State Street Corporation 6.6% Alberta Corporate Registry
Marshall Wace LLP 3.6% Alberta Corporate Registry
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund 2.9% Alberta Corporate Registry

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

Directors and officers of Aurinia Pharmaceuticals Inc.

The President, Ceo & Director of Aurinia Pharmaceuticals Inc. currently on record is Peter S. Greenleaf M.b.a.; five officers are currently on record for Aurinia Pharmaceuticals Inc., filed with Alberta Corporate Registry. Management authority at Aurinia Pharmaceuticals Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Data availability

The register reports 12 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Data-provider feed — rows as supplied to Zavia for Alberta Corporate Registry, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

PS
Peter S. Greenleaf M.b.a. ACTIVE

Residence
🇨🇦 Canada
Occupation
President, Ceo & Director

GF
Gregory F. Keenan M.d. ACTIVE

Residence
🇨🇦 Canada
Occupation
Chief Medical Officer

MR
Michael R. Martin ACTIVE

Residence
🇨🇦 Canada
Occupation
Chief Business Officer

SP
Stephen P. Robertson ACTIVE

Residence
🇨🇦 Canada
Occupation
Executive Vice President Of General Counsel

PR
Premchandran Ramiya Ph.d. ACTIVE

Residence
🇨🇦 Canada
Occupation
Senior Vice President Of Manufacturing & Supply Chain

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

Group structure of Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

  • AURINIA PHARMA U.S., INC.

Data availability

Those 1 subsidiary spans Canada jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Data-provider feed — rows as supplied to Zavia for Alberta Corporate Registry, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Ultimate HQ
Aurinia Pharmaceuticals Inc.
Canada
AURINIA PHARMA U.S., INC.
US MD F20673661

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on Aurinia Pharmaceuticals Inc.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns Aurinia Pharmaceuticals Inc.?

Five shareholders are currently on record for Aurinia Pharmaceuticals Inc., reflecting the securities register maintained under sections 20 and 50 of the Canada Business Corporations Act rather than a public filing. The largest of these is Tang Capital Management, LLC, holding 27.8% — the largest recorded stake — followed by Arrowstreet Capital, Limited Partnership at 8.3%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is Aurinia Pharmaceuticals Inc.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for Aurinia Pharmaceuticals Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does Aurinia Pharmaceuticals Inc. have on record?

5 shareholders are shown on record for Aurinia Pharmaceuticals Inc.. The register reports 16 in total; only the top 5 by holding are shown here.

Is Aurinia Pharmaceuticals Inc. still an active company?

Aurinia Pharmaceuticals Inc.'s status on Alberta Corporate Registry is listed as active.

What is Aurinia Pharmaceuticals Inc.'s registered address?

The registered address on file for Aurinia Pharmaceuticals Inc. is Edmonton, Canada.

What legal structure is Aurinia Pharmaceuticals Inc. registered as?

Aurinia Pharmaceuticals Inc. is registered as a Public Limited Company in Canada.

Who are the officers/directors of Aurinia Pharmaceuticals Inc.?

The President, Ceo & Director of Aurinia Pharmaceuticals Inc. currently on record is Peter S. Greenleaf M.b.a.; five officers are currently on record for Aurinia Pharmaceuticals Inc., filed with Alberta Corporate Registry. Management authority at Aurinia Pharmaceuticals Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does Aurinia Pharmaceuticals Inc. have a parent company or subsidiaries?

Aurinia Pharmaceuticals Inc. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Those 1 subsidiary spans Canada jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Can Zavia monitor changes to Aurinia Pharmaceuticals Inc.'s ownership over time?

This profile reflects a point-in-time snapshot from Alberta Corporate Registry. Zavia's monitoring API can track changes to Aurinia Pharmaceuticals Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access Aurinia Pharmaceuticals Inc.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Canada, so records like Aurinia Pharmaceuticals Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Alberta Corporate Registry and was last synced on 28 September 2026.

This website uses cookies to improve your web experience.